4SCIARRA F, TOSCANO V. Role of estrogens in human benign prostatic hyperplasia[J]. Arch Androl, 2000, 44(3): 213-220.
5陈培栋.九品香水莲花问世[J].中国花卉园艺,2004,(24):38.
6Lucy J.S., Donald J.T. Steroid 5ct-reductase inhibitors targeting BPH and prostate cancer[J]. J. Steroid Biochem. Mol. Biol., 2011, 125: 32-38.
7Benzie IF, Strain JJ. The ferric reducing ability of plasma as a measure of 'antioxidant power': the FRAP assay[J] Journal of Analytical Biochemistry, 1996, 239(1) : 70-76.
8Niu Yinong, Ge Rongbin, Hu Libing, et al. Reduced levels of 5a-reductase 2 in adult prostate tissue and impli- cations for BPH Therapy[J]. The Prostate, 2011, 71:1317-1324.
9Thapana K, Chaiyavat C, Vandee R, et al. Screening of steriod 5ct-reductase inhibitory activity and total phenoliccontent of Thai plants[J]. Journal of Medicinal Plants Research, 2011, 5(7): 1265-1271.
10Cho C.H., Bae J.S., Kim Y.U. 5a-reductase inhibitory components as antiandrogens from herbal medicine[J]. J. Acupunc- ture and Meridian Studies, 2010, 3: 116-118.
